SEPTERNA, INC.

Profile

Company Names

SEPTERNA, INC.

Addresses

250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-338-3533

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$73,499,988.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2023-06-28 
$73,499,988.00 
$149,999,989.00 
$76,500,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ABRAHAM 
 
BASSAN 
DIRECTOR
GRAPHITE BIO, INC.   |  CARGO THERAPEUTICS, INC.   |  SEPTERNA, INC.   |  SAMSARA OPPORTUNITY FUND, L.P.   |  RANI THERAPEUTICS HOLDINGS, INC.
ELIZABETH 
 
BHATT 
EXECUTIVE OFFICER
SEPTERNA, INC.
ALAN 
 
EZEKOWITZ 
DIRECTOR
ABIDE THERAPEUTICS, INC.   |  FULCRUM THERAPEUTICS, INC.   |  SEPTERNA, INC.   |  CORNER THERAPEUTICS, INC.
JEFFREY 
 
FINER 
EXECUTIVE OFFICER, DIRECTOR
SEPTERNA, INC.
SAMIRA 
 
SHAIKHLY 
EXECUTIVE OFFICER
SEPTERNA, INC.
JAKE 
 
SIMSON 
DIRECTOR
AAVANTIBIO, INC.   |  DICE MOLECULES HOLDINGS, LLC   |  CEDILLA THERAPEUTICS, INC.   |  CONVERGENT THERAPEUTICS, INC.   |  SEPTERNA, INC.   |  OUTPACE BIO, INC.   |  VIVACE THERAPEUTICS, INC.
JEFFREY 
 
TONG 
DIRECTOR
THIRD ROCK VENTURES V, L.P.   |  ASHER BIOTHERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.   |  SEPTERNA, INC.
RAN 
 
XIAO 
EXECUTIVE OFFICER
SEPTERNA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-07-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#